Serotonin rebalances cortical tuning and behavior linked to autism symptoms in 15q11-13 CNV mice

Nobuhiro Nakai(Hiroshima University), Masatoshi Nagano(Nippon Medical School), Fumihito Saitow(Nippon Medical School), Yasuhito Watanabe(Hiroshima University), Yoshinobu Kawamura(Hiroshima University), Akiko Kawamoto(Hiroshima University), Kota Tamada(Hiroshima University), Hiroshi Mizuma(CE Technologies (United Kingdom)), Hirotaka Onoe(CE Technologies (United Kingdom)), Yasuyoshi Watanabe(Hiroshima University), Hiromu Monai(RIKEN Center for Brain Science), Hajime Hirase(RIKEN Center for Brain Science), Jin Nakatani(Shiga University of Medical Science), Hirofumi Inagaki(Nippon Medical School), Tomoyuki Kawada(Nippon Medical School), Taisuke Miyazaki(Hokkaido University), Masahiko Watanabe(Hokkaido University), Yuka Sato(The University of Tokyo), Shigeo Okabe(The University of Tokyo), K. Kitamura(The University of Tokyo), Masanobu Kano(The University of Tokyo), Kouichi Hashimoto(Hiroshima University), Hidenori Suzuki(Japan Science and Technology Agency), Toru Takumi(Hiroshima University)
Science Advances
June 2, 2017
Cited by 84Open Access
Full Text

Abstract

mice revealed the reversibility of a subset of ASD-related symptoms in the adult. These findings suggest that serotonin may have therapeutic potential for discrete ASD symptoms.


Related Papers

No related papers found

Powered by citation graph analysis